When MO-I-500 was used as an FTO inhibitor to downregulate the expression of FTO in astrocytes, the survival rate increased significantly, oxidative stress and cell apoptosis were significantly reduced, and mitochondrial dysfunction and energy metabolism disorder were significantly improved, exhibiting the toxic effect of FTO and the nerve protective effect of its inhibitor in AD [62]. This evidence concerns the gene FTO and Alzheimer disease.